Fulvestrant in advanced breast cancer: evidence to date and place in therapy

Breast cancer is a classical hormone-dependent tumour; therefore, endocrine therapy is the mainstay of treatment for hormone receptor-positive, human epidermal growth factor 2-negative advanced breast cancer. Until recently, classical endocrine agents such as tamoxifen, steroidal and nonsteroidal ar...

Descripción completa

Detalles Bibliográficos
Autor principal: Boér, Katalin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502950/
https://www.ncbi.nlm.nih.gov/pubmed/28717399
http://dx.doi.org/10.1177/1758834017711097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502950/
https://www.ncbi.nlm.nih.gov/pubmed/28717399
http://dx.doi.org/10.1177/1758834017711097

Ejemplares similares